首页 | 本学科首页   官方微博 | 高级检索  
     


Fetal blood chromosome analysis: some new indications for prenatal karyotyping
Authors:CHRISTINE GOSDEN Member  Medical Resarch Council's Scientific Staff andHornory Senior Lecturer  C. H. RRODECK Director  Harris Birthright Research Centre for Fetal Medicine  K. H. NICOLAIDES Lecturer  Harris Birthright Research Centre for Fetd Medicine  S. CAMPBELL Professor  PATRICIA EASON Senior Technician   J. C. SHARP Senior Lecturerl Consltant
Affiliation:MRC Clinical wid Popullation Cytogenetics Unit, Western General Hospital, Edinburgh EH4 2XU, London SE5 8RX;Department of Obstetrics rind Gynaccologv, London SE5 8RX;Department of Haematology, King's College and School of Medicine and Dentistry. Denmark Hl1, London SE5 8RX
Abstract:Summary. Prenatal karyotyping using stimulated fetal blood lymphocytes was undertaken in 170 pregnancies between 16 and 36 weeks gestation for the following reasons-(1) mosaicism or marker chromo somes found in amniotic fluid culture; (2) a family history of X-linked mental retardation with fragile Xq28; (3) fetal abnormalities detected ultrasonographically; (4) late booking or amniotic fluid culture failure in patients with advanced age or balanced translocations; and ( 5 ) twin pregnancies discordant for a chromosomal anomaly. Forty-one karyotypic abnormalities were detected (24%). These were: 45,X (7 cases). trisomy 13 ( 5 cases), trisomy 18 (6 cases), trisomy 21 (4 cases), twin pregnancy where one twin had trisomy 21 (1 case), supernumerary marker chromosome (3 cases, one of which occurred in a twin pregnancy). triploidy (3 cases), X-linked mental retardation with fragile site at Xq28 in males (6 cases), fetal erythroleukaemia (3 cases including 2 cases with Turner's), Fanconi's anaemia (1 case), unbalanced chromosome translocation 47,XY+der22,t(l1;22) mat (1 case), mos 46,XXI8p-/46,XX.-18,+i(l8q) (1 case), 46,XXde1(2q) (1 case), and 46,XYt(5;17) de novo (1 case). In fetuses at high risk of a chromosome aberration. a rapidly obtaincd karyotype is helpful and fetoscopy and fetal blood sampling are justified in the second or third trimester.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号